US Stock MarketDetailed Quotes

OLMA Olema Pharmaceuticals

Watchlist
  • 5.890
  • +0.320+5.75%
Close Jan 3 16:00 ET
  • 5.890
  • 0.0000.00%
Post 16:34 ET
434.72MMarket Cap-2.58P/E (TTM)

Olema Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Olema Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Olema Pharmaceuticals Earnings Reports

  • Olema Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 16:22 ET

  • Olema Pharmaceuticals | 8-K: Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 12, 2024 16:16 ET

  • Olema Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6, 2024 16:20 ET

  • Olema Pharmaceuticals | 8-K: Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 6, 2024 16:18 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DexCom
    DXCM
    +3.27%
    Collegium Pharmaceutical
    COLL
    +3.07%
    Lantheus
    LNTH
    +2.71%
    Cars.com
    CARS
    +1.72%
    YETI Holdings
    YETI
    +1.60%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data